A Bio-equivalence Study of Sofosbuvir From Elbanovir 400 mg Film Coated Tablets ( Multi-Apex Pharma, Egypt) & Sovaldi 400 mg Film Coated Tablets (Gilead Sciences, United Kingdom)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

October 31, 2015

Conditions

Healthy

Interventions

DRUG

Elbanovir

1 tablet contains 400 mg sofosbuvir

DRUG

Sovaldi

1 tablet contains 400 mg sofosbuvir

DRUG

Sovaldi

1 tablet contains 400 mg sofosbuvir

Trial Locations (1)

Genuine Research Center GRC, Cairo